Time: 10:00 AM - 11:00 AM EST
Speaker: Chris Forespring, Sr. Manager, BioProcess Engineering , MedImmune
Register to join us. Mention priority code Webinar_FOB
About the web seminar:
Thorough evaluation of emerging technologies is a key determinant for identifying process improvement opportunities in existing and future bioprocess facilities. Successful implementation through process coupling and/or elimination of non-value added processing steps could result in both novel facility-fit solutions with alternative processing options and provide major cost savings at clinical and commercial scales.
In this context, a collaborative study has been undertaken to demonstrate the use of Cadence™ Inline Concentrator (ILC) linked to several potential processing steps such as perfusion, pre-capture chromatography, in-process volume reduction, and UF/DF. ILC is a disposable, self-contained, and easy to use, single-pass tangential flow filtration (TFF) device. The feasibility and performance of ILC modules were successfully evaluated and demonstrated over a wide range of feed streams at varying concentrations and process temperatures.
Participants will learn:
- -How the ILC technology is an important addition to the process development toolbox for platform process development.
- - How the ILC can remove constraints in existing facilities and increase the flexibility of manufacturing.
- - Specific ILC applications with industrial biomolecules and the impact on the existing processes through detailed end-user case studies.
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment